This fund typically commits a minimum of 80% of its capital to the securities of companies predominantly involved in the medical technology industry. This includes firms engaged in the research, development, manufacturing, distribution, or sale of medical equipment and related technologies, as well as those supporting drug discovery, and companies providing information technology services primarily to healthcare providers. Its holdings largely consist of common stocks, and it invests in both domestic and international issuers. This is designated as a non-diversified fund.